IL141639A - Multicomponent vaccines - Google Patents
Multicomponent vaccinesInfo
- Publication number
- IL141639A IL141639A IL14163999A IL14163999A IL141639A IL 141639 A IL141639 A IL 141639A IL 14163999 A IL14163999 A IL 14163999A IL 14163999 A IL14163999 A IL 14163999A IL 141639 A IL141639 A IL 141639A
- Authority
- IL
- Israel
- Prior art keywords
- proteins
- fragments
- fragment
- protein
- bacterial
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000014914 Carrier Proteins Human genes 0.000 abstract 3
- 108091008324 binding proteins Proteins 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 101710198480 Clumping factor A Proteins 0.000 abstract 1
- 101710198481 Clumping factor B Proteins 0.000 abstract 1
- 241001574013 Collogenes Species 0.000 abstract 1
- 206010041925 Staphylococcal infections Diseases 0.000 abstract 1
- 241000191940 Staphylococcus Species 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000029586 bacterial cell surface binding Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9843998P | 1998-08-31 | 1998-08-31 | |
PCT/US1999/019727 WO2000012131A1 (fr) | 1998-08-31 | 1999-08-31 | Vaccins a plusieurs constituants |
Publications (2)
Publication Number | Publication Date |
---|---|
IL141639A0 IL141639A0 (en) | 2002-03-10 |
IL141639A true IL141639A (en) | 2005-12-18 |
Family
ID=22269290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14163999A IL141639A (en) | 1998-08-31 | 1999-08-31 | Multicomponent vaccines |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1109577B1 (fr) |
JP (2) | JP2002523473A (fr) |
KR (1) | KR100644953B1 (fr) |
CN (1) | CN1314450C (fr) |
AT (1) | ATE422368T1 (fr) |
AU (1) | AU771426B2 (fr) |
BR (1) | BR9913340A (fr) |
CA (2) | CA2777661C (fr) |
DE (1) | DE69940404D1 (fr) |
ES (1) | ES2322409T3 (fr) |
IL (1) | IL141639A (fr) |
MX (1) | MXPA01002119A (fr) |
WO (1) | WO2000012131A1 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692739B1 (en) | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
JP4714342B2 (ja) | 1998-08-31 | 2011-06-29 | ザ プラヴアスト フエロウス アンド スカラース オブ ザ カレツヂ オブ ザ ハリー アンド アンデイヴアイデツド トリニテイ オブ クイーン エリザベス ニヤー ダブリン | コアグラーゼ陰性スタフィロコカス菌に由来のポリペプチド及びポリヌクレオチド |
WO2000012132A1 (fr) * | 1998-08-31 | 2000-03-09 | Inhibitex, Inc. | Procede d'immunotherapie contre les infections staphylococciques comprenant la selection des donneurs et la stimulation des donneurs |
GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
CA2425000A1 (fr) * | 2000-10-20 | 2002-05-02 | Inhibitex, Inc. | Anticorps monoclonaux diriges contre la proteine map et procede d'utilisation de ceux-ci dans le traitement ou la prevention des infections |
EP1481011A4 (fr) * | 2002-03-05 | 2007-05-30 | Inhibitex Inc | Anticorps monoclonaux et polyclonaux reconnaissant des proteines staphylocoques a coagulase negative |
WO2004080490A2 (fr) | 2003-03-07 | 2004-09-23 | Wyeth Holdings Corporation | Conjugues de proteine-polysaccharide porteuse d'adhesine superficielle staphylococcique pour immunisation contre des infections nosocomiales |
WO2004094600A2 (fr) * | 2003-04-16 | 2004-11-04 | The Texas A & M University System | Proteine efb issue de staphylococcus aureus et region de liaison a c3 inhibant l'activation du complement |
WO2004110367A2 (fr) * | 2003-05-29 | 2004-12-23 | Inhibitex, Inc. | Proteines sdr du staphylocoque capitis et utilisation associee dans la prevention et le traitement d'infections |
BRPI0515520A (pt) * | 2004-09-22 | 2008-07-29 | Glaxosmithkline Biolog Sa | composição imunogênica, vacina, métodos de preparar uma vacina e de prevenir ou tratar infecção estafilocócica, e, uso de composição imunogênica |
US7829294B2 (en) * | 2004-12-28 | 2010-11-09 | Daiichi Pure Chemicals Co., Ltd. | Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
GB0526038D0 (en) | 2005-12-21 | 2006-02-01 | Glaxosmithkline Biolog Sa | Immunogenic composition |
EP2368570A3 (fr) * | 2006-01-18 | 2012-05-02 | University Of Chicago | Compositions et procédés liés aux protéines des bactéries staphylocoques |
US20100021503A1 (en) * | 2006-03-30 | 2010-01-28 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
CA2693239A1 (fr) * | 2007-07-23 | 2009-01-29 | Vaccine Research International Plc | Vaccin a cellules entieres staphylococciques inactivees |
US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
EP2666784B1 (fr) | 2007-08-31 | 2017-04-05 | University Of Chicago | Méthodes et compositions associées à l'immunisation contre des maladies et d'affections pulmonaires staphylococciques |
WO2009111337A1 (fr) | 2008-03-03 | 2009-09-11 | Irm Llc | Composés et compositions servant de modulateurs de l’activité des tlr |
WO2010014304A1 (fr) | 2008-07-29 | 2010-02-04 | University Of Chicago | Compositions et procédés apparentés à des protéines de bactérie staphylococcique |
EP2414387B1 (fr) | 2009-04-03 | 2015-12-16 | University Of Chicago | Compositions et méthodes associées aux variants de la protéine a (spa) |
AU2010258677B2 (en) | 2009-06-10 | 2016-10-06 | Glaxosmithkline Biologicals S.A. | Benzonaphthyridine-containing vaccines |
RU2536981C9 (ru) | 2009-06-22 | 2015-05-10 | ВАЙЕТ ЭлЭлСи | Иммуногенные композиции антигенов staphylococcus aureus |
SA114350400B1 (ar) | 2009-06-22 | 2016-05-26 | ويث ال ال سي | تركيبات وطرق لتحضير تركيبات مولدة للمناعة لمقترن بولي سكاريد كبسولي للنمط المصلي 5 و 8 من المكورات العنقودية الذهبية |
AU2010271582B2 (en) | 2009-07-15 | 2016-07-28 | Aimm Therapeutics B.V. | Gram-positive bacteria specific binding compounds |
DK2459216T3 (da) | 2009-09-02 | 2013-12-09 | Novartis Ag | Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer |
JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
WO2011057148A1 (fr) | 2009-11-05 | 2011-05-12 | Irm Llc | Composés et compositions permettant de moduler l'activité des tlr-7 |
SG10201501980SA (en) | 2009-12-15 | 2015-05-28 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
CA2792938C (fr) | 2010-03-23 | 2018-07-31 | Irm Llc | Composes (lipopeptides a base de cysteine) et compositions en tant qu'agonistes des tlr2 utilises pour traiter des infections, inflammations, maladies respiratoires entre autres |
CN103037885B (zh) | 2010-07-02 | 2015-08-26 | 芝加哥大学 | 与蛋白A(SpA)变体相关的组合物和方法 |
US9192661B2 (en) | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
PL3150222T3 (pl) * | 2010-12-22 | 2020-05-18 | Wyeth Llc | Stabilne immunogenne kompozycje antygenów staphylococcus aureus |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
EP2848257A4 (fr) * | 2012-05-07 | 2015-12-02 | Mogam Biotechnology Inst | Composition de vaccin pour prévenir une infection par staphylococcus aureus |
WO2014118305A1 (fr) | 2013-02-01 | 2014-08-07 | Novartis Ag | Administration intradermique de compositions immunologiques comprenant des agonistes des récepteurs de type toll |
MX2017007652A (es) * | 2014-12-10 | 2017-10-11 | Glaxosmithkline Biologicals Sa | Metodo de tratamiento. |
CN107007832A (zh) * | 2016-01-28 | 2017-08-04 | 中创云牧科技咨询(北京)股份有限公司 | 一种ClfA-A靶位的金黄色葡萄球菌奶牛乳房炎疫苗的制备方法 |
CA3090271A1 (fr) | 2018-02-12 | 2019-08-15 | Inimmune Corporation | Ligands du recepteur de type toll |
KR102528412B1 (ko) * | 2020-09-08 | 2023-05-04 | 클립스비엔씨 주식회사 | 신규한 포도상구균 감염 질환의 예방 또는 치료용 조성물 |
CA3198924A1 (fr) | 2020-11-04 | 2022-05-12 | Eligo Bioscience | Particules derivees de phages pour l'administration in situ de charge utile d'adn dans une population de c. acnes |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5189015A (en) * | 1984-05-30 | 1993-02-23 | Alfa-Laval Agri International Ab | Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability |
SE454403B (sv) * | 1984-05-30 | 1988-05-02 | Alfa Laval Agri Int | Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel |
US5730978A (en) * | 1989-09-01 | 1998-03-24 | Fred Hutchinson Cancer Research Center | Inhibition of lymphocyte adherence with α4β1-specific antibodies |
US5440014A (en) * | 1990-08-10 | 1995-08-08 | H+E,Uml/Oo/ K; Magnus | Fibronectin binding peptide |
US5851794A (en) * | 1990-10-22 | 1998-12-22 | Alfa Laval Ab | Collagen binding protein as well as its preparation |
US5648240A (en) * | 1994-05-24 | 1997-07-15 | Texas A&M University | MHC II analog from Staphylococcus aureus |
US6288214B1 (en) * | 1996-05-16 | 2001-09-11 | Texas A&M University Systems | Collagen binding protein compositions and methods of use |
SE9602496D0 (sv) * | 1996-06-20 | 1996-06-20 | Bengt Guss | Method and means for producing a fibrinogen binding protein and its use in biotechnology |
AU744723B2 (en) * | 1997-01-21 | 2002-02-28 | The Texas A & M University System | Fibronectin binding protein compositions, and methods of use |
AU1537699A (en) * | 1997-11-26 | 1999-06-15 | Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency | Extracellular matrix-binding proteins from (staphylococcus aureus) |
-
1999
- 1999-08-31 ES ES99942533T patent/ES2322409T3/es not_active Expired - Lifetime
- 1999-08-31 MX MXPA01002119A patent/MXPA01002119A/es active IP Right Grant
- 1999-08-31 CA CA2777661A patent/CA2777661C/fr not_active Expired - Lifetime
- 1999-08-31 AU AU55889/99A patent/AU771426B2/en not_active Expired
- 1999-08-31 CN CNB998104884A patent/CN1314450C/zh not_active Expired - Lifetime
- 1999-08-31 WO PCT/US1999/019727 patent/WO2000012131A1/fr active IP Right Grant
- 1999-08-31 EP EP99942533A patent/EP1109577B1/fr not_active Expired - Lifetime
- 1999-08-31 DE DE69940404T patent/DE69940404D1/de not_active Expired - Lifetime
- 1999-08-31 JP JP2000567242A patent/JP2002523473A/ja active Pending
- 1999-08-31 KR KR1020017002672A patent/KR100644953B1/ko not_active IP Right Cessation
- 1999-08-31 CA CA2340304A patent/CA2340304C/fr not_active Expired - Lifetime
- 1999-08-31 IL IL14163999A patent/IL141639A/xx not_active IP Right Cessation
- 1999-08-31 AT AT99942533T patent/ATE422368T1/de not_active IP Right Cessation
- 1999-08-31 BR BR9913340-7A patent/BR9913340A/pt not_active Application Discontinuation
-
2011
- 2011-04-14 JP JP2011089946A patent/JP5460642B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2340304A1 (fr) | 2000-03-09 |
AU5588999A (en) | 2000-03-21 |
ES2322409T3 (es) | 2009-06-19 |
KR20010085745A (ko) | 2001-09-07 |
DE69940404D1 (de) | 2009-03-26 |
CA2340304C (fr) | 2012-12-04 |
CA2777661C (fr) | 2014-10-21 |
CN1317976A (zh) | 2001-10-17 |
AU771426B2 (en) | 2004-03-18 |
JP2011168607A (ja) | 2011-09-01 |
WO2000012131A1 (fr) | 2000-03-09 |
JP2002523473A (ja) | 2002-07-30 |
EP1109577B1 (fr) | 2009-02-11 |
ATE422368T1 (de) | 2009-02-15 |
EP1109577A1 (fr) | 2001-06-27 |
IL141639A0 (en) | 2002-03-10 |
KR100644953B1 (ko) | 2006-11-10 |
JP5460642B2 (ja) | 2014-04-02 |
CA2777661A1 (fr) | 2000-03-09 |
CN1314450C (zh) | 2007-05-09 |
MXPA01002119A (es) | 2003-03-27 |
BR9913340A (pt) | 2001-11-06 |
EP1109577A4 (fr) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL141639A0 (en) | Multicomponent vaccines | |
WO2002072600A3 (fr) | Anticorps monoclonaux contre la proteine clfa et procede d'utilisation dans le traitement et la prevention d'infections | |
WO1999027109A3 (fr) | PROTEINES LIANT LA MATRICE EXTRACELLULAIRE ISSUES DU $i(STAPHILOCOCCUS AUREUS) | |
AU3126097A (en) | Collagen binding protein compositions and methods of use | |
EP1203817A3 (fr) | Composés et procédés pour l'immunothérapie et le diagnostic de la tuberculose | |
WO2001052791A3 (fr) | Complexes de fragments de liaison peptidique de proteines de choc thermique et leur utilisation comme agents immmunotherapeutiques | |
HUP9901186A2 (hu) | Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra | |
AU2002305450A1 (en) | Proteomimetic compounds and methods | |
EP1731166A3 (fr) | Protéines et vaccins de streptococcus pneumoniae | |
GB0103169D0 (en) | Vaccine composition | |
WO2002075507A3 (fr) | Preparations de vaccin anti-bacteriennes | |
DE69914911D1 (de) | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen | |
WO2000061724A3 (fr) | Compositions vaccinales anti-bacteriennes | |
DE69728975D1 (de) | Rekombinante phagen | |
WO2021158755A3 (fr) | Protéines leptospirales et leurs utilisations | |
GB9723945D0 (en) | Tissue cement | |
WO2000063386A3 (fr) | Prevention, diagnostic et traitement de la maladie de lyme | |
EP1574579A3 (fr) | Protéines de membranes externes, leurs gènes, et leur utilisation | |
WO2002057281A3 (fr) | Aminoglycosides utilises comme antibiotiques | |
DE60024977D1 (de) | Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen | |
NO20042711L (no) | Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum | |
WO2002077648A3 (fr) | Antigenes vaccinaux de nesseria pathogenes et commensaux | |
WO2003072607A8 (fr) | Anticorps monoclonaux a reaction croisee contre des proteines de liaison de collagene bacterien | |
AU2002224437A1 (en) | Monoclonal antibodies to the map protein and method of use in treating or preventing infections | |
CA2171369A1 (fr) | Utilisation d'aggressines d'agents pathogenes permettant d'ameliorer l'administration liposomique d'antibiotiques et (ou) de vaccins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |